Equities

TruBridge Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

TruBridge Inc

Actions
Health CareHealth Care Providers
  • Price (USD)19.22
  • Today's Change0.115 / 0.60%
  • Shares traded24.79k
  • 1 Year change-31.76%
  • Beta0.6512
Data delayed at least 15 minutes, as of Mar 04 2026 19:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.

  • Revenue in USD (TTM)349.88m
  • Net income in USD5.42m
  • Incorporated2002
  • Employees3.20k
  • Location
    TruBridge Inc54 St. Emanuel StreetMOBILE 36602United StatesUSA
  • Phone+1 (251) 639-8100
  • Fax+1 (302) 636-5454
  • Websitehttps://trubridge.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Simulations Plus Inc78.68m-64.25m238.94m212.00--1.88--3.04-3.20-3.203.906.310.4701--4.28371,113.20-38.39-2.50-40.84-2.6559.6069.96-81.66-7.29----0.00--13.0913.74-750.17--7.57-24.21
Cibus Inc3.79m-118.90m239.69m157.00--3.68--63.18-3.26-3.260.09720.95880.0109--4.2324,165.61-36.11-80.24-39.32-89.98-----3,322.54-1,268.46---2.180.8131--134.56-10.196.07---22.92--
Orchestra Biomed Holdings Inc2.82m-75.10m246.19m70.00--5.63--87.36-1.82-1.820.06760.77460.03130.657833.7540,257.14-83.39---104.85--93.01---2,665.05--4.72--0.2451---4.42---24.23------
CapsoVision Inc13.09m-22.56m249.67m----12.20--19.08-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
Applied Energetics Inc1.15m-13.02m250.26m21.00------217.04-0.0599-0.05990.0053-0.00330.3065--7.7054,908.57-345.27-139.08-454.84-208.3658.5860.61-1,126.59-473.16---------7.78---24.71--51.42--
Clearpoint Neuro Inc34.33m-23.14m262.83m115.00--15.82--7.66-0.8264-0.82641.230.55840.68291.957.52298,539.10-46.03-35.94-54.48-41.4861.3163.49-67.40-74.875.56-92.370.6479--31.0422.8514.37--11.41--
Shoulder Innovations Inc41.63m-34.45m269.06m61.00--1.82--6.46-1.91-1.912.247.18----------------76.67---82.75--9.80--0.0913--64.07---50.85------
Quanterix Corp130.20m-95.66m275.54m471.00--0.8712--2.12-2.33-2.333.216.740.30451.444.06276,439.50-22.37-13.18-25.81-14.5351.5356.14-73.47-45.092.31--0.0029--12.3019.36-35.89---20.86--
Sight Sciences Inc76.05m-46.11m278.11m216.00--4.29--3.66-0.8955-0.89551.471.230.58541.426.71352,092.60-35.49-35.50-39.37-38.5386.8382.63-60.63-94.208.93-76.380.384---1.4727.897.27---10.54--
Senseonics Holdings Inc29.30m-63.77m278.86m117.00--3.56--9.52-1.65-1.650.75651.920.2483.625.22250,410.30-53.98-71.11-70.98-94.7541.11-14.81-217.65-594.095.93-29.180.3109--0.36621.08-30.18--16.46--
Trubridge Inc349.88m5.42m286.67m3.20k51.491.598.940.81930.37090.370924.2312.020.8737257.086.17109,338.401.39-0.91071.60-1.0353.1650.131.59-1.141.902.400.4768--0.9464.5256.05--61.10--
Delcath Systems Inc85.23m2.70m298.82m156.00137.052.68101.713.510.06280.06282.183.210.85141.377.53546,352.602.70-54.432.95-69.7186.1684.723.17-102.109.98--0.00--129.08120.21110.23--14.62--
Rxsight Inc134.48m-38.94m314.45m461.00--1.14--2.34-0.9533-0.95333.296.680.42671.175.03291,713.70-12.36-21.94-13.47-24.1076.6064.71-28.96-52.979.75--0.0003---3.8955.74-41.85--8.57--
Owlet Inc99.64m-42.45m326.55m80.00------3.28-2.75-2.756.08-2.341.523.804.361,245,500.00-60.37-64.44-244.32-331.1152.0644.29-39.68-58.720.9074-2.48----44.529.4054.08---17.23--
Data as of Mar 04 2026. Currency figures normalised to TruBridge Inc's reporting currency: US Dollar USD

Institutional shareholders

62.81%Per cent of shares held by top holders
HolderShares% Held
Pinetree Capital Ltd. (Investment Management)as of 12 Jan 20262.98m19.86%
Ocho Investments LLCas of 13 Mar 20251.12m7.45%
Strikwerda Investments BVas of 22 Sep 2025950.16k6.33%
Nellore Capital Management LLCas of 31 Dec 2025915.03k6.10%
Camac Partners LLCas of 31 Dec 2025861.64k5.74%
BlackRock Fund Advisorsas of 31 Dec 2025692.63k4.62%
The Vanguard Group, Inc.as of 31 Dec 2025661.45k4.41%
Dimensional Fund Advisors LPas of 31 Dec 2025470.94k3.14%
Martin & Co., Inc.as of 31 Dec 2025437.03k2.91%
Paradigm Capital Management, Inc.as of 31 Dec 2025339.00k2.26%
More ▼
Data from 22 Sep 2025 - 06 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.